CAPZA3
Basic information
Region (hg38): 12:18738119-18739188
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAPZA3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 24 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 0 | 0 |
Variants in CAPZA3
This is a list of pathogenic ClinVar variants found in the CAPZA3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-18738281-G-A | not specified | Uncertain significance (Oct 18, 2021) | ||
12-18738289-C-A | not specified | Uncertain significance (Jan 30, 2024) | ||
12-18738291-G-T | not specified | Uncertain significance (Dec 14, 2024) | ||
12-18738357-C-G | not specified | Uncertain significance (May 26, 2023) | ||
12-18738416-T-C | not specified | Uncertain significance (Apr 06, 2024) | ||
12-18738503-G-A | not specified | Uncertain significance (Aug 28, 2024) | ||
12-18738506-G-A | not specified | Uncertain significance (Jul 13, 2021) | ||
12-18738524-C-G | not specified | Uncertain significance (Jul 20, 2021) | ||
12-18738636-G-A | not specified | Uncertain significance (Mar 03, 2022) | ||
12-18738638-G-A | not specified | Uncertain significance (Dec 15, 2023) | ||
12-18738733-T-G | not specified | Uncertain significance (Feb 28, 2025) | ||
12-18738743-A-C | not specified | Uncertain significance (Apr 08, 2024) | ||
12-18738750-A-T | not specified | Uncertain significance (May 08, 2024) | ||
12-18738753-C-A | not specified | Uncertain significance (Jan 08, 2024) | ||
12-18738860-T-A | not specified | Uncertain significance (Jan 20, 2025) | ||
12-18738876-T-C | not specified | Uncertain significance (Jul 13, 2021) | ||
12-18738936-T-G | not specified | Uncertain significance (Mar 24, 2023) | ||
12-18738944-G-T | not specified | Uncertain significance (Dec 16, 2022) | ||
12-18738953-G-A | not specified | Uncertain significance (Jul 19, 2022) | ||
12-18738970-C-A | not specified | Uncertain significance (Sep 20, 2024) | ||
12-18738987-T-C | not specified | Uncertain significance (Jun 16, 2023) | ||
12-18739010-T-C | not specified | Uncertain significance (Jan 03, 2025) | ||
12-18739038-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
12-18739042-G-C | not specified | Uncertain significance (Aug 21, 2023) | ||
12-18739059-G-T | not specified | Uncertain significance (Sep 25, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CAPZA3 | protein_coding | protein_coding | ENST00000317658 | 1 | 1077 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000971 | 0.825 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.257 | 164 | 155 | 1.06 | 0.00000753 | 1980 |
Missense in Polyphen | 53 | 52.902 | 1.0018 | 705 | ||
Synonymous | -0.799 | 67 | 59.2 | 1.13 | 0.00000306 | 554 |
Loss of Function | 1.17 | 6 | 9.97 | 0.602 | 6.06e-7 | 114 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: F-actin-capping proteins bind in a Ca(2+)-independent manner to the fast growing ends of actin filaments (barbed end) thereby blocking the exchange of subunits at these ends. Unlike other capping proteins (such as gelsolin and severin), these proteins do not sever actin filaments. May play a role in the morphogenesis of spermatid (By similarity). {ECO:0000250}.;
- Pathway
- Endocytosis - Homo sapiens (human);Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;COPI-independent Golgi-to-ER retrograde traffic;Golgi-to-ER retrograde transport;COPI-mediated anterograde transport;ER to Golgi Anterograde Transport;Intra-Golgi and retrograde Golgi-to-ER traffic
(Consensus)
Recessive Scores
- pRec
- 0.0999
Intolerance Scores
- loftool
- 0.237
- rvis_EVS
- 0.09
- rvis_percentile_EVS
- 60.47
Haploinsufficiency Scores
- pHI
- 0.252
- hipred
- N
- hipred_score
- 0.248
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.199
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Capza3
- Phenotype
- reproductive system phenotype;
Gene ontology
- Biological process
- endoplasmic reticulum to Golgi vesicle-mediated transport;spermatid development;antigen processing and presentation of exogenous peptide antigen via MHC class II;actin cytoskeleton organization;barbed-end actin filament capping
- Cellular component
- acrosomal vesicle;nucleus;cytosol;F-actin capping protein complex;membrane;actin cortical patch
- Molecular function
- actin filament binding